|
|
Volumn 35, Issue 3 SUPPL., 2003, Pages S37-S51
|
|
Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
PREDNISOLONE;
RAPAMYCIN;
ADOLESCENT;
ADULT;
AGED;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HYPERLIPIDEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
KIDNEY TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT NEOPLASTIC DISEASE;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
SURVIVAL RATE;
TRIACYLGLYCEROL BLOOD LEVEL;
|
|
EID: 0038637990
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00353-1 Document Type: Conference Paper |
|
Times cited : (77)
|
|
References (20)
|
